Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279-Reference-Cited by-同舟云学术

Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279

Published:2023-07-10 Issue:15 Volume:66 Page:10473-10496
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Leit Silvana¹,Greenwood Jeremy²,Carriero Samantha¹,Mondal Sayan²,Abel Robert²,Ashwell Mark¹,Blanchette Heather¹,Boyles Nicholas A.²,Cartwright Mark¹,Collis Alan¹,Feng Shulu²,Ghanakota Phani²^ORCID,Harriman Geraldine C.¹,Hosagrahara Vinayak¹,Kaila Neelu¹,Kapeller Rosanna¹,Rafi Salma B.²,Romero Donna L.¹,Tarantino Paul M.¹,Timaniya Jignesh³,Toms Angela V.¹,Wester Ronald T.¹,Westlin William¹,Srivastava Bhaskar¹,Miao Wenyan¹,Tummino Peter¹,McElwee Joshua J.¹,Edmondson Scott D.¹^ORCID,Masse Craig E.¹

Affiliation:

1. Nimbus Therapeutics, 22 Boston Wharf Road, Floor 9, Boston, Massachusetts 02210, United States

2. Schrödinger, Inc., 1540 Broadway, New York, New York 10036, United States

3. Piramal Pharma Solutions, Plot No. 18, Pharmez, Ahmedabad 382215, Gujarat, India

Funder

Nimbus Therapeutics

Schr??dinger, Inc.,

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link